Serum Lipidomics Profiling to Identify Biomarkers for Non-Small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide, which ranks top in both incidence and mortality. To broaden our understanding of the lipid metabolic alterations in NSCLC and to identify potential biomarkers for early diagnosis, we performed nontargeted lipidomics a...
Main Authors: | Yingrong Chen, Zhihong Ma, Xiongrong Shen, Liqin Li, Jing Zhong, Li Shan Min, Limin Xu, Hongwei Li, Jianbin Zhang, Licheng Dai |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2018/5276240 |
Similar Items
-
Simultaneous quantification of serum monounsaturated and polyunsaturated phosphatidylcholines as potential biomarkers for diagnosing non-small cell lung cancer
by: Yingrong Chen, et al.
Published: (2018-05-01) -
Biomarker Identification and Pathway Analysis by Serum Metabolomics of Lung Cancer
by: Yingrong Chen, et al.
Published: (2015-01-01) -
Lipidomic Profiling for Serum Biomarkers in Mice Exposed to Ionizing Radiation
by: Jinfeng Huang, et al.
Published: (2020-04-01) -
Hearing Loss in Alzheimer’s Disease Is Associated with Altered Serum Lipidomic Biomarker Profiles
by: Daniel A. Llano, et al.
Published: (2020-11-01) -
Seminal Plasma Lipidomics Profiling to Identify Signatures of Kallmann Syndrome
by: Xiaogang Li, et al.
Published: (2021-07-01)